The problem of antibiotic-resistant bacteria has many health experts worried. As disease-causing bacteria adapt to some of our ways to reduce them, especially with antibiotics, it presents an arms ...

CareDx recently issued preliminary, unaudited guidance for fourth-quarter 2025 revenue of about US$108 million and full-year 2025 revenue of roughly US$380 million, indicating solid year-over-year ...

TL;DR: AMD announced at CES 2026 that its next-generation Instinct MI500 AI accelerators, launching in 2027, will feature TSMC's advanced 2nm process, CDNA 6 architecture, and next-gen HBM4E memory.

Wacker and Gearbox Biosciences agreed to collaborate to advance plasmid DNA manufacturing technologies. By combining Wacker’s expertise in GMP manufacturing of biologics, including pDNA, with Gearbox ...

CareDx has a unique, comprehensive organ transplant diagnostics portfolio and maintains strong revenue growth, but faces intensifying competition and regulatory risks. Recent legal resolutions and ...

The CALM suppression and replacement gene-therapy approach simultaneously silences all 3 endogenous CALM genes while introducing a modified CALM1 cDNA transcript, resulting in the production of a ...

Scientists have identified essential genetic code for a method called plasmid curing, which aims to 'displace' antibiotic resistance genes from bacteria. Birmingham scientists have identified ...

$CDNA insiders have traded $CDNA stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales. Here’s a ...

CareDx (CDNA) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to loss of $0.03 per share a year ago. These figures are ...

According to Precedence Research, the global plasmid DNA manufacturing market size accounted for USD 2.64 billion in 2025 and is expected to reach around USD 11.33 billion by 2034, growing at a CAGR ...

SAN CARLOS, Calif.--(BUSINESS WIRE)--Elegen, the leader in next-generation DNA manufacturing, today announced the launch of ENFINIA™ Plasmid DNA, a faster, cost-effective solution for clonal synthesis ...